Europe faces measles outbreak

Backstory: The pandemic and growing hesitancy slowed vaccinations. A false claim in the 1990s that the combined measles-mumps-rubella vaccine caused…

Zepbound is off to a good start, but here's what Eli Lilly investors are watching

Hopes are sky-high for Eli Lilly's recently launched weight-loss drug Zepbound. Investors will tune into the company's fourth-quarter earnings conference…